COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

Patients with multiple myeloma have a compromised immune system, due to both the disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID-19. Here, we report outcomes and risk factors for serious disease in patients with multiple myeloma treated at five large academi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara A., Patel, Dhwani, Smith, Eric L., Korde, Neha, Lu, Sydney X., Mailankody, Sham, Shah, Urvi A., Lesokhin, Alexander M., Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkach, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetzky, David, Braunstein, Marc J., Gordillo, Christian, Reshef, Ran, Taur, Ying, Davies, Faith E., Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth J., Landgren, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668224/
https://www.ncbi.nlm.nih.gov/pubmed/34651141
http://dx.doi.org/10.1158/2643-3230.BCD-20-0102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668224/
https://www.ncbi.nlm.nih.gov/pubmed/34651141
http://dx.doi.org/10.1158/2643-3230.BCD-20-0102

Ejemplares similares